‘I’m scared about my future’: young people on the stress and desperation of jobseeking | BusinessNovember 15, 2026
General Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapyBy Healthcare Propulsion StaffNovember 11, 20260 Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will…
General Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 MeetingBy Healthcare Propulsion StaffNovember 5, 20260 Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for…
